In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction

Mario Manto, Josep Dalmau, Adrien Didelot, Véronique Rogemond, Jérôme Honnorat

Open source

DOI
10.1186/1750-1172-5-31
Published
2010-11-26
Container
Orphanet Journal of Rare Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1750-1172-5-31,
  title = {In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction},
  author = {Mario Manto and Josep Dalmau and Adrien Didelot and Véronique Rogemond and Jérôme Honnorat},
  year = {2010},
  journal = {Orphanet Journal of Rare Diseases},
  doi = {10.1186/1750-1172-5-31},
  url = {https://doi.org/10.1186/1750-1172-5-31}
}

RIS

TY  - JOUR
TI  - In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction
AU  - Mario Manto
AU  - Josep Dalmau
AU  - Adrien Didelot
AU  - Véronique Rogemond
AU  - Jérôme Honnorat
PY  - 2010
JO  - Orphanet Journal of Rare Diseases
DO  - 10.1186/1750-1172-5-31
UR  - https://doi.org/10.1186/1750-1172-5-31
ER  - 

APA

Manto, M., Dalmau, J., Didelot, A., Rogemond, V., & Honnorat, J. (2010). In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-5-31

Source records